Seven ADR reports of gangrene and/or peripheral cyanosis associated with the use of norepinephrine [noradrenaline; Cardiamed] News item 19 January 2013 Pages: 3 - 3
Health Canada has received 189 ADR reports suspected to be associated with atomoxetine use, according to Heather Morrison from Health Canada. News item 19 January 2013 Pages: 3 - 3
A phase I trial of AV-1142742 [RhuDex] is on hold while the death of a volunteer is investigated Media release 19 January 2013 Pages: 3 - 3
Rate of lisdexamfetamine-related ADRs unexpectedly high Non-clinical study 19 January 2013 Pages: 4 - 4